| Autor: |
Al-Osaimi HM; Department of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia., Kanan M; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia., Marghlani L; Department of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia., Al-Rowaili B; Pharmaceutical Services Department, Northern Area Armed Forces Hospital, King Khalid Military, Hafr Al Batin, Kingdom of Saudi Arabia., Albalawi R; Department of Medicine, Tabuk University, Tabuk, Kingdom of Saudi Arabia., Saad A; Pharmacy Department, Royal Commission Hospital, Yanbu, Kingdom of Saudi Arabia., Alasmari S; Department of Clinical Pharmacy, King Khalid University, Jeddah, Kingdom of Saudi Arabia., Althobaiti K; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Alhulaili Z; Department of Clinical Pharmacy, Dammam Medical Complex, Dammam, Kingdom of Saudi Arabia., Alanzi A; Department of Medicine, King Abdulaziz Hospital, Makkah, Kingdom of Saudi Arabia., Alqarni R; Department of Medicine and Surgery, King Khalid University, Abha, Kingdom of Saudi Arabia., Alsofiyani R; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Shrwani R; Department of Clinical Pharmacy, Jazan University, Jazan, Kingdom of Saudi Arabia. |
| Abstrakt: |
Insect vector-borne diseases (VBDs) pose significant global health challenges, particularly in tropical and subtropical regions. The WHO has launched the "Global Vector Control Response (GVCR) 2017-2030" to address these diseases, emphasizing a comprehensive approach to vector control. This systematic review investigates the potential of malaria and dengue vaccines in controlling mosquito-borne VBDs, aiming to alleviate disease burdens and enhance public health. Following PRISMA 2020 guidelines, the review incorporated 39 new studies out of 934 identified records. It encompasses various studies assessing malaria and dengue vaccines, emphasizing the significance of vaccination as a preventive measure. The findings indicate variations in vaccine efficacy, duration of protection, and safety considerations for each disease, influencing public health strategies. The review underscores the urgent need for vaccines to combat the increasing burden of VBDs like malaria and dengue, advocating for ongoing research and investment in vaccine development. |
